| Financial Year |
March 31 2023 |
| Monetary Funds |
71,479,298.20 |
| Held-for-trading Financial Assets |
110,595,833.63 |
| Notes Receivable |
2,477,997.59 |
| Accounts Receivable |
976,102,034.58 |
| Advances to Suppliers |
15,421,139.67 |
| Other Receivables |
15,129,095.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
61,062,159.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
231,755,335.76 |
| Total Current Assets |
1,484,522,894.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,912,933.55 |
| Investment Properties |
-- |
| Fixed Assetes |
515,954,584.87 |
| Under-construction Projects |
14,566,703.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,624,614,597.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
104,842,737.26 |
| Deferred Income Tax Assets |
40,978,221.83 |
| Other Non-Current Assets |
97,157,604.71 |
| Sub-Total of Non-Current Assets |
6,816,041,027.20 |
| Total Assets |
8,300,563,921.35 |
| Short-Term Loans |
83,071,709.49 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
612,013,505.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,954,657.35 |
| Taxes Payable |
30,332,191.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,319,546.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
503,593,909.27 |
| Other Current Liabilities |
2,320,000.00 |
| Sub-Total of Current Liabilities |
1,254,605,519.71 |
| Long-term Loans |
3,295,279,091.94 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
209,332,638.02 |
| Special Payable |
-- |
| Estimatied Liabilities |
59,820,428.45 |
| Deferred Income Tax Liabilities |
25,772,239.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,636,168,392.10 |
| Total Liabilities |
4,890,773,911.81 |
| Paid-In Capital(Or Share Stock) |
271,741,053.00 |
| Capital Surplus |
1,413,287,035.81 |
| Surplus Reserve |
76,550,781.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,640,130,947.30 |
| Minority Stockholder's Interest |
5,110,169.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,404,679,839.73 |
| Owner's Equity（Stockholder's Equity） |
3,409,790,009.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,300,563,921.35 |
